Review



human embryonic kidney cell line hek293t  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human embryonic kidney cell line hek293t
    Human Embryonic Kidney Cell Line Hek293t, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 38849 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney cell line hek293t/product/ATCC
    Average 99 stars, based on 38849 article reviews
    human embryonic kidney cell line hek293t - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC human embryonic kidney cell line hek293t
    Human Embryonic Kidney Cell Line Hek293t, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney cell line hek293t/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney cell line hek293t - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC cell lines human embryonic kidney cell line hek293t cells
    Cell Lines Human Embryonic Kidney Cell Line Hek293t Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human embryonic kidney cell line hek293t cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell lines human embryonic kidney cell line hek293t cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC sv40 transformed human embryonic kidney 293t hek293t cell line
    Sv40 Transformed Human Embryonic Kidney 293t Hek293t Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sv40 transformed human embryonic kidney 293t hek293t cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    sv40 transformed human embryonic kidney 293t hek293t cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney hek293t crl 3216 cell line
    Human Embryonic Kidney Hek293t Crl 3216 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek293t crl 3216 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney hek293t crl 3216 cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC cell lines hek293t human embryonic kidney cells atcc 293t
    Cell Lines Hek293t Human Embryonic Kidney Cells Atcc 293t, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines hek293t human embryonic kidney cells atcc 293t/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell lines hek293t human embryonic kidney cells atcc 293t - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney hek293t cell line
    Comparison of cell viability, assessed by MTT method in the DMEM culture medium, after exposure to ( A ) Al_GO/P sample extracts by indirect contact assay and ( B ) after direct contact with the Al_GO/P samples; at ( i ) 24-hour and ( ii ) 48-hour. Data are expressed as % values of result obtained in comparison to control cells <t>(HEK293T)</t> not exposed to materials or material extracts. Results from indirect contact assay showed Al_GO/P substrates maintained optimal biocompatibility compared to bare Al over 48 hours. While direct contact assay indicated high cell viability for Al_GO50P and Al_GO100P, with Al_GO250P showing minor viability changes at 48 hours, while significant decreases were observed for Al_GO500P and Al_GO1000P over 48 hours. Error bars represent ±1 standard deviation (SD) from mean forthree independent biological replicates (n=3). Statistical significance was assessed using one-way ANOVA; specific p-values of <0.05, <0.01, <0.001, and <0.0001 were indicated as *,**,***, and ****, respectively.
    Human Embryonic Kidney Hek293t Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek293t cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney hek293t cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney 293t hek293t cell line
    UXT-V2 inhibits HSV-2 replication via NF-κB independent pathway. A ARPE-19 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 1 μg) or His-UXT-V2 (0.5 or 1 μg), followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The virus yields were measured by plaque assay. B HeLa cells were transfected with 0.3 μg PRD(III-I) 4 -Luc or NF-κB–Luc reporter plasmid along with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V1 or His-UXT-V2, followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The luciferase activity was measured to determine the activation fold. <t>HEK293T</t> cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. C HEK293T cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. D BHK-21 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 24 hpi. E BHK-21 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. F Vero E6 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested and the virus yields were measured by plaque assay at 24 hpi. G Vero E6 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. H Vero E6 cells transfected with the control or the two UXT shRNAs, respectively, were infected with HSV-2 at an MOI of 0.2 PFU/cell for 24 h. The virus yields were measured by plaque assay. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001; ns, not significant). For images, one representative experiment out of three is shown.
    Human Embryonic Kidney 293t Hek293t Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney 293t hek293t cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney 293t hek293t cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of cell viability, assessed by MTT method in the DMEM culture medium, after exposure to ( A ) Al_GO/P sample extracts by indirect contact assay and ( B ) after direct contact with the Al_GO/P samples; at ( i ) 24-hour and ( ii ) 48-hour. Data are expressed as % values of result obtained in comparison to control cells (HEK293T) not exposed to materials or material extracts. Results from indirect contact assay showed Al_GO/P substrates maintained optimal biocompatibility compared to bare Al over 48 hours. While direct contact assay indicated high cell viability for Al_GO50P and Al_GO100P, with Al_GO250P showing minor viability changes at 48 hours, while significant decreases were observed for Al_GO500P and Al_GO1000P over 48 hours. Error bars represent ±1 standard deviation (SD) from mean forthree independent biological replicates (n=3). Statistical significance was assessed using one-way ANOVA; specific p-values of <0.05, <0.01, <0.001, and <0.0001 were indicated as *,**,***, and ****, respectively.

    Journal: bioRxiv

    Article Title: Enhancing the biocorrosion resistance and biocompatibility of Aluminium substrates using Graphene Oxide-PEDOT:PSS Hybrid Coating

    doi: 10.1101/2025.09.29.679258

    Figure Lengend Snippet: Comparison of cell viability, assessed by MTT method in the DMEM culture medium, after exposure to ( A ) Al_GO/P sample extracts by indirect contact assay and ( B ) after direct contact with the Al_GO/P samples; at ( i ) 24-hour and ( ii ) 48-hour. Data are expressed as % values of result obtained in comparison to control cells (HEK293T) not exposed to materials or material extracts. Results from indirect contact assay showed Al_GO/P substrates maintained optimal biocompatibility compared to bare Al over 48 hours. While direct contact assay indicated high cell viability for Al_GO50P and Al_GO100P, with Al_GO250P showing minor viability changes at 48 hours, while significant decreases were observed for Al_GO500P and Al_GO1000P over 48 hours. Error bars represent ±1 standard deviation (SD) from mean forthree independent biological replicates (n=3). Statistical significance was assessed using one-way ANOVA; specific p-values of <0.05, <0.01, <0.001, and <0.0001 were indicated as *,**,***, and ****, respectively.

    Article Snippet: The Human Embryonic Kidney (HEK293T) cell line [ATCC CRL-11268] was used.

    Techniques: Comparison, Control, Standard Deviation

    UXT-V2 inhibits HSV-2 replication via NF-κB independent pathway. A ARPE-19 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 1 μg) or His-UXT-V2 (0.5 or 1 μg), followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The virus yields were measured by plaque assay. B HeLa cells were transfected with 0.3 μg PRD(III-I) 4 -Luc or NF-κB–Luc reporter plasmid along with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V1 or His-UXT-V2, followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The luciferase activity was measured to determine the activation fold. HEK293T cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. C HEK293T cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. D BHK-21 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 24 hpi. E BHK-21 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. F Vero E6 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested and the virus yields were measured by plaque assay at 24 hpi. G Vero E6 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. H Vero E6 cells transfected with the control or the two UXT shRNAs, respectively, were infected with HSV-2 at an MOI of 0.2 PFU/cell for 24 h. The virus yields were measured by plaque assay. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001; ns, not significant). For images, one representative experiment out of three is shown.

    Journal: Virologica Sinica

    Article Title: Ubiquitously expressed transcript isoform 2 (UXT-V2) restricts HSV-2 replication by targeting glycoprotein B for degradation through ubiquitin-proteasome pathway

    doi: 10.1016/j.virs.2025.08.004

    Figure Lengend Snippet: UXT-V2 inhibits HSV-2 replication via NF-κB independent pathway. A ARPE-19 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 1 μg) or His-UXT-V2 (0.5 or 1 μg), followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The virus yields were measured by plaque assay. B HeLa cells were transfected with 0.3 μg PRD(III-I) 4 -Luc or NF-κB–Luc reporter plasmid along with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V1 or His-UXT-V2, followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. The luciferase activity was measured to determine the activation fold. HEK293T cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. C HEK293T cells were transfected with 0.3 μg NF-κB-Luc reporter plasmid along with an empty vector or 1 μg plasmid expressing His-UXT-V2 for 24 h, followed by treatment with or without 10 ng/mL TNF-α for 6 h. Luciferase activity was measured to determine the activation fold. D BHK-21 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 24 hpi. E BHK-21 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with JEV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. F Vero E6 cells were transfected with an empty vector or different doses of plasmids expressing His-UXT-V1 (0.5 or 2 μg) or His-UXT-V2 (0.5 or 2 μg), followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested and the virus yields were measured by plaque assay at 24 hpi. G Vero E6 cells were transfected with an empty vector or 1.5 μg plasmid expressing His-UXT-V2, followed by infection with ZIKV at an MOI of 0.5 PFU/cell at 6 hpt. The supernatants and cells were harvested, and the virus yields were measured by plaque assay at 8, 16, 24 and 36 hpi. H Vero E6 cells transfected with the control or the two UXT shRNAs, respectively, were infected with HSV-2 at an MOI of 0.2 PFU/cell for 24 h. The virus yields were measured by plaque assay. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001; ns, not significant). For images, one representative experiment out of three is shown.

    Article Snippet: Human embryonic kidney 293T (HEK293T) cell line, baby hamster kidney cell line BHK-21, African green monkey kidney cell line Vero and Vero E6, and human cervical epithelial cell line HeLa were purchased from the American Type Culture Collection.

    Techniques: Transfection, Plasmid Preparation, Expressing, Infection, Virus, Plaque Assay, Luciferase, Activity Assay, Activation Assay, Control

    UXT-V2 downregulates the expression of HSV-2 gB. A HSV-2 proteins fished out by LC-MS/MS analysis. Figure was created using ggplot2. B HEK293T cells were co-transfected with 2 μg empty vector or 2 μg His-UXT-V2 together with 2 μg plasmid expressing Flag-gB. At 24 hpi, cells were harvested and lysed, and the extracts were subjected to IP using the anti-Flag MAb or control IgG. C HeLa cells were infected with or without HSV-2 at an MOI of 0.2 PFU/cell. At 24 hpi, cells were harvested and lysed, and the extracts were subjected to IP using the anti-gB MAb. D HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing various Flag-tagged HSV-2 proteins for 24 h. The expression of Flag-tagged HSV-2 proteins were measured by Western blotting. E HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 or 18 h. Cells were harvested and the expression of Flag-gB was detected by Western blotting. F HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V1 or His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 or 18 h. Cells were harvested and the expression of Flag-gB was measured by Western blotting. G ARPE-19 cells were transfected with 60 nM NC or #4 (UXT-V2 siRNA), followed by transfection with an empty vector or different doses of plasmids expressing Flag-gB (0.5 or 2 μg) for 24 h. Cells were harvested and the expression of Flag-gB was detected by Western blotting. H HeLa cells were transfected with an empty vector or 2 μg plasmid expressing His-UXT-V2, followed by infection with HSV-2 at an MOI of 5 PFU/cell. At 6 or 8 hpi, cells were harvested, and the expression level of HSV-2 gB or gD was analyzed by Western blotting. I WT and UXT-V2-KO HeLa cells were infected with HSV-2 at an MOI of 5 PFU/cell. At 6 or 8 hpi, cells were harvested and the expression level of HSV-2 gB or gD was measured by Western blotting. J HeLa cells were co-transfected with an empty vector or different doses of plasmids expressing His-UXT-V2 (0.5 or 2 μg) together with 0.5 μg plasmid expressing Flag-gB, followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. Virus yields were measured by plaque assay. The graph shows compensating efficiency of gB on HSV-2 yields. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001; ns, not significant). For images, one representative experiment out of three is shown.

    Journal: Virologica Sinica

    Article Title: Ubiquitously expressed transcript isoform 2 (UXT-V2) restricts HSV-2 replication by targeting glycoprotein B for degradation through ubiquitin-proteasome pathway

    doi: 10.1016/j.virs.2025.08.004

    Figure Lengend Snippet: UXT-V2 downregulates the expression of HSV-2 gB. A HSV-2 proteins fished out by LC-MS/MS analysis. Figure was created using ggplot2. B HEK293T cells were co-transfected with 2 μg empty vector or 2 μg His-UXT-V2 together with 2 μg plasmid expressing Flag-gB. At 24 hpi, cells were harvested and lysed, and the extracts were subjected to IP using the anti-Flag MAb or control IgG. C HeLa cells were infected with or without HSV-2 at an MOI of 0.2 PFU/cell. At 24 hpi, cells were harvested and lysed, and the extracts were subjected to IP using the anti-gB MAb. D HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing various Flag-tagged HSV-2 proteins for 24 h. The expression of Flag-tagged HSV-2 proteins were measured by Western blotting. E HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 or 18 h. Cells were harvested and the expression of Flag-gB was detected by Western blotting. F HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V1 or His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 or 18 h. Cells were harvested and the expression of Flag-gB was measured by Western blotting. G ARPE-19 cells were transfected with 60 nM NC or #4 (UXT-V2 siRNA), followed by transfection with an empty vector or different doses of plasmids expressing Flag-gB (0.5 or 2 μg) for 24 h. Cells were harvested and the expression of Flag-gB was detected by Western blotting. H HeLa cells were transfected with an empty vector or 2 μg plasmid expressing His-UXT-V2, followed by infection with HSV-2 at an MOI of 5 PFU/cell. At 6 or 8 hpi, cells were harvested, and the expression level of HSV-2 gB or gD was analyzed by Western blotting. I WT and UXT-V2-KO HeLa cells were infected with HSV-2 at an MOI of 5 PFU/cell. At 6 or 8 hpi, cells were harvested and the expression level of HSV-2 gB or gD was measured by Western blotting. J HeLa cells were co-transfected with an empty vector or different doses of plasmids expressing His-UXT-V2 (0.5 or 2 μg) together with 0.5 μg plasmid expressing Flag-gB, followed by infection with HSV-2 at an MOI of 0.2 PFU/cell at 6 hpt for 18 h. Virus yields were measured by plaque assay. The graph shows compensating efficiency of gB on HSV-2 yields. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001; ns, not significant). For images, one representative experiment out of three is shown.

    Article Snippet: Human embryonic kidney 293T (HEK293T) cell line, baby hamster kidney cell line BHK-21, African green monkey kidney cell line Vero and Vero E6, and human cervical epithelial cell line HeLa were purchased from the American Type Culture Collection.

    Techniques: Expressing, Liquid Chromatography with Mass Spectroscopy, Transfection, Plasmid Preparation, Control, Infection, Western Blot, Virus, Plaque Assay

    UXT-V2 induces gB degradation through proteasomal pathways. A HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 h or 18 h. Cells were harvested and the transcripts of gB were detected by relative quantitative PCR. B HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. C HEK293T cells were transfected with 1 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM), 3-MA (5 or 20 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. D HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM), 3-MA (5 or 20 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (ns, not significant). For images, one representative experiment out of three is shown.

    Journal: Virologica Sinica

    Article Title: Ubiquitously expressed transcript isoform 2 (UXT-V2) restricts HSV-2 replication by targeting glycoprotein B for degradation through ubiquitin-proteasome pathway

    doi: 10.1016/j.virs.2025.08.004

    Figure Lengend Snippet: UXT-V2 induces gB degradation through proteasomal pathways. A HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB for 12 h or 18 h. Cells were harvested and the transcripts of gB were detected by relative quantitative PCR. B HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. C HEK293T cells were transfected with 1 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM), 3-MA (5 or 20 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. D HEK293T cells were co-transfected with 1.5 μg empty vector or 1.5 μg plasmid expressing His-UXT-V2 together with 0.5 μg plasmid expressing Flag-gB in the absence or presence of CQ (20 or 100 μM), 3-MA (5 or 20 μM) or MG132 (1 or 2 μM). At 24 hpt, the expression of Flag-gB was detected by Western blotting. For graphs, data shown are mean ± SD of three independent experiments with each condition performed in triplicate (ns, not significant). For images, one representative experiment out of three is shown.

    Article Snippet: Human embryonic kidney 293T (HEK293T) cell line, baby hamster kidney cell line BHK-21, African green monkey kidney cell line Vero and Vero E6, and human cervical epithelial cell line HeLa were purchased from the American Type Culture Collection.

    Techniques: Transfection, Plasmid Preparation, Expressing, Real-time Polymerase Chain Reaction, Western Blot

    UXT-V2 promotes K48-linked polyubiquitination of HSV-2 gB. A HEK293T cells were co-transfected with 0.5 μg empty vector or different doses of plasmids expressing His-UXT-V2 (0.2, 0.5 or 1.5 μg) together with 0.5 μg plasmid expressing HA-Ub. At 24 hpt, the expression of His-UXT-V2 and ubiquitinated cellular proteins was detected by Western blotting. B HEK293T cells were transfected with 0.5 μg empty vector or different doses of plasmids expressing His-UXT-V2 (0.2, 0.5 or 1.5 μg). At 24 hpt, the expression of His-UXT-V2 and ubiquitinated cellular proteins was detected by Western blotting. C HEK293T cells were co-transfected with 5 μg empty vector or 5 μg plasmid expressing His-UXT-V2 together with 4 μg plasmid expressing Flag-gB for 24 h. Cells were immunoprecipitated with the anti-Flag MAb. D HEK293T cells were co-transfected with 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2 together with 2 μg plasmid expressing Flag-gB and 2 μg plasmid expressing HA-Ub, HA-K48 or HA-K63 for 24 h. Cells were immunoprecipitated with the indicated antibodies. E HeLa cells were co-transfected with 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2 together with 2 μg plasmid expressing HA-Ub, HA-K48 or HA-K63, followed by infection with HSV-2 at an MOI of 2 PFU/cell at 6 hpt for 18 h. Cells were immunoprecipitated with the indicated antibodies. For images, one representative experiment out of three is shown.

    Journal: Virologica Sinica

    Article Title: Ubiquitously expressed transcript isoform 2 (UXT-V2) restricts HSV-2 replication by targeting glycoprotein B for degradation through ubiquitin-proteasome pathway

    doi: 10.1016/j.virs.2025.08.004

    Figure Lengend Snippet: UXT-V2 promotes K48-linked polyubiquitination of HSV-2 gB. A HEK293T cells were co-transfected with 0.5 μg empty vector or different doses of plasmids expressing His-UXT-V2 (0.2, 0.5 or 1.5 μg) together with 0.5 μg plasmid expressing HA-Ub. At 24 hpt, the expression of His-UXT-V2 and ubiquitinated cellular proteins was detected by Western blotting. B HEK293T cells were transfected with 0.5 μg empty vector or different doses of plasmids expressing His-UXT-V2 (0.2, 0.5 or 1.5 μg). At 24 hpt, the expression of His-UXT-V2 and ubiquitinated cellular proteins was detected by Western blotting. C HEK293T cells were co-transfected with 5 μg empty vector or 5 μg plasmid expressing His-UXT-V2 together with 4 μg plasmid expressing Flag-gB for 24 h. Cells were immunoprecipitated with the anti-Flag MAb. D HEK293T cells were co-transfected with 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2 together with 2 μg plasmid expressing Flag-gB and 2 μg plasmid expressing HA-Ub, HA-K48 or HA-K63 for 24 h. Cells were immunoprecipitated with the indicated antibodies. E HeLa cells were co-transfected with 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2 together with 2 μg plasmid expressing HA-Ub, HA-K48 or HA-K63, followed by infection with HSV-2 at an MOI of 2 PFU/cell at 6 hpt for 18 h. Cells were immunoprecipitated with the indicated antibodies. For images, one representative experiment out of three is shown.

    Article Snippet: Human embryonic kidney 293T (HEK293T) cell line, baby hamster kidney cell line BHK-21, African green monkey kidney cell line Vero and Vero E6, and human cervical epithelial cell line HeLa were purchased from the American Type Culture Collection.

    Techniques: Transfection, Plasmid Preparation, Expressing, Western Blot, Immunoprecipitation, Infection

    UXT-V2 facilitates TRIM21-dependent proteasomal degradation of gB. A E3 ubiquitin ligases fished out by LC-MS/MS analysis. Figure was created using ggplot2. B HEK293T cells were co-transfected either with 2 μg empty vector or 2 μg HA-TRIM21 expression plasmid, along with 2 μg plasmid expressing Flag-gB. At 24 hpt, cells were harvested and lysed, followed by IP using the anti-Flag MAb or control IgG. C The expression of TRIM21 in sgControl and sgTRIM21 HeLa cells was assessed by immunoblot analysis. D HeLa or TRIM21-KO HeLa cells were co-transfected with either 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2, along with 2 μg plasmid expressing Flag-gB and 2 μg plasmid expressing HA-K48. At 24 hpt, cells were harvested and lysed, followed by IP using the anti-Flag Mab or control IgG. For images, one representative experiment out of three is shown.

    Journal: Virologica Sinica

    Article Title: Ubiquitously expressed transcript isoform 2 (UXT-V2) restricts HSV-2 replication by targeting glycoprotein B for degradation through ubiquitin-proteasome pathway

    doi: 10.1016/j.virs.2025.08.004

    Figure Lengend Snippet: UXT-V2 facilitates TRIM21-dependent proteasomal degradation of gB. A E3 ubiquitin ligases fished out by LC-MS/MS analysis. Figure was created using ggplot2. B HEK293T cells were co-transfected either with 2 μg empty vector or 2 μg HA-TRIM21 expression plasmid, along with 2 μg plasmid expressing Flag-gB. At 24 hpt, cells were harvested and lysed, followed by IP using the anti-Flag MAb or control IgG. C The expression of TRIM21 in sgControl and sgTRIM21 HeLa cells was assessed by immunoblot analysis. D HeLa or TRIM21-KO HeLa cells were co-transfected with either 2 μg empty vector or 2 μg plasmid expressing His-UXT-V2, along with 2 μg plasmid expressing Flag-gB and 2 μg plasmid expressing HA-K48. At 24 hpt, cells were harvested and lysed, followed by IP using the anti-Flag Mab or control IgG. For images, one representative experiment out of three is shown.

    Article Snippet: Human embryonic kidney 293T (HEK293T) cell line, baby hamster kidney cell line BHK-21, African green monkey kidney cell line Vero and Vero E6, and human cervical epithelial cell line HeLa were purchased from the American Type Culture Collection.

    Techniques: Ubiquitin Proteomics, Liquid Chromatography with Mass Spectroscopy, Transfection, Plasmid Preparation, Expressing, Control, Western Blot